Table 1.
Preoperative and operative patient’s characteristics
| p value |
Wallace group (66 patients) |
Bricker group (69 patients) |
Variables |
|---|---|---|---|
| 132 | 134 | Renal units, n | |
| 0.53 | 67.6 (9) | 66.6 (10.8) | Age (years), mean (SD) |
| 0.34 | 48 (72.7) | 55 (79.7) | Male gender, n (%) |
| 0.58 | 27 (4.4) | 26.7 (5.4) | BMI (kg/m2), mean (SD) |
| 0.03 | 1.2 (0.4) | 1 (0.4) | Preoperative serum creatinine (mg ∕dl), mean (SD) |
| 0.00 | 29 (43.9) | 15 (21.7) | GFR (ml/min/1.73 m2) < 60, n (%) |
| 0.26 | 11 (16.6) | 7 (10.1) | Diabetes, n (%) |
| 0.74 | 24 (36.3) | 27 (39.1) | Vascular disease, n (%) |
| 0.85 | 21(31.8) | 23 (33.3) | Smoking history, n (%) |
| 0.76 | 27 (40.9) | 30 (43.9) | ASA score ≥ 3, n (%) |
| 0.5 |
5 (7.6) 8 (12.1) |
9 (13) 8 (11.6) |
Preoperative hydronephrosis, n (%) Unilateral Bilateral |
| 0.67 | 5 (7.5) | 4 (5.8) | Preoperative chemotherapy, n (%) |
| 0.26 | 6 (9.1) | 3 (4.3) | History of pelvic radiotherapy, n (%) |
| 0.7 | 9 (13.6) | 11 (15.9) | History of abdominal surgery, n (%) |
| 0.07 |
7 (10.9) 54 (81.8) 2 (3) 1 (1.5) 2 (3) |
1 (1.4) 66 (95.7) 2 (2.9) 0 0 |
Indication for cystectomy, n (%) Benign disease Bladder cancer Prostate cancer Gynecologic cancer Colorectal cancer |
| 0.38 |
54 (81.8) 10 (15.1) 2(3) |
50 (72.4) 17 (24.6) 2 (2.9) |
Diversion technique, n (%) Ileal conduit Orthotopic neobladder Continent cutaneous |
| 0.9 | 2 (3) | 2 (2.9) | Distant Metastasis, n (%) |